MX9702209A - Dna que codifica para virus de papiloma humano tipo 6a. - Google Patents

Dna que codifica para virus de papiloma humano tipo 6a.

Info

Publication number
MX9702209A
MX9702209A MX9702209A MX9702209A MX9702209A MX 9702209 A MX9702209 A MX 9702209A MX 9702209 A MX9702209 A MX 9702209A MX 9702209 A MX9702209 A MX 9702209A MX 9702209 A MX9702209 A MX 9702209A
Authority
MX
Mexico
Prior art keywords
human papillomavirus
papillomavirus type
dna encoding
encoding human
type
Prior art date
Application number
MX9702209A
Other languages
English (en)
Other versions
MXPA97002209A (es
Inventor
Kathrin U Jansen
Kathryn J Hofmann
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23202654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9702209(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MX9702209A publication Critical patent/MX9702209A/es
Publication of MXPA97002209A publication Critical patent/MXPA97002209A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invencion está dirigida a moléculas de DNA que codifican para virus de papiloma humano tipo 6a y compuestos derivados a partir del mismo.
MXPA/A/1997/002209A 1994-09-22 1997-03-20 Dna que codifica para virus de papiloma humano tipo 6a MXPA97002209A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31046894A 1994-09-22 1994-09-22
US310468 1994-09-22
PCT/US1995/011859 WO1996009375A1 (en) 1994-09-22 1995-09-18 Dna encoding human papillomavirus type 6a

Publications (2)

Publication Number Publication Date
MX9702209A true MX9702209A (es) 1997-07-31
MXPA97002209A MXPA97002209A (es) 1997-12-01

Family

ID=

Also Published As

Publication number Publication date
WO1996009375A1 (en) 1996-03-28
NZ293461A (en) 1998-04-27
AU3591895A (en) 1996-04-09
EP0782615A1 (en) 1997-07-09
FI971203A (fi) 1997-03-21
CA2200582A1 (en) 1996-03-28
CA2200582C (en) 2007-03-27
BR9509076A (pt) 1998-07-14
NO971347L (no) 1997-05-21
NO971347D0 (no) 1997-03-21
PL319294A1 (en) 1997-08-04
HUT77337A (hu) 1998-03-30
EP0782615A4 (en) 2001-08-22
BG101338A (en) 1997-10-31
CZ87597A3 (cs) 1998-01-14
FI971203A0 (fi) 1997-03-21
JPH10506014A (ja) 1998-06-16
RU2177999C2 (ru) 2002-01-10
AU694269B2 (en) 1998-07-16
SK35897A3 (en) 1998-02-04
US6290965B1 (en) 2001-09-18
FI121507B (fi) 2010-12-15

Similar Documents

Publication Publication Date Title
IL114003A0 (en) Bicyclic compounds
GR3033850T3 (en) Chloropyrimide intermediates
BG101338A (en) Dna encoding human papillomavirus type 6a
MY111201A (en) New imidazopyridines
ZA962245B (en) Dna encoding human papillomavirus type 18
ZA962526B (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
BG102818A (en) D-manitol and method for its preparation
CA2215834A1 (en) Dna encoding human papillomavirus type 18
FI972030A (fi) Puhdistettuja papillomavirusproteiineja
AU4376396A (en) Use of andrographolide compounds to treat or prevent pathogenicity of diseases
GB9425730D0 (en) Compounds
GB9507844D0 (en) Improvements relating to the collection of process effluent
MY124071A (en) Treatment of viral disease in swine
AU4202096A (en) The use of sertraline to treat cancer patients
PL343758A1 (en) Purification of carboxaldehyde
BR9706702A (pt) Purificação de 1,1,1,3,3-pentafluorpropano
DE69526731D1 (en) Hypocholesterolämische,antiatherosklerotische und hypotriglyceridämische mercaptoacetylamid-derivate
GB9214449D0 (en) Purification of 1,1,1,2-tetrafluoroethane
IL124354A0 (en) Hemoregulatory compounds
GB9508521D0 (en) Improvements relating to the coding of products
UA28287A (uk) Спосіб приготування грязьового препарату для електрофоретичних процедур
GB9422873D0 (en) Authentication of individuals by analysis of human-computer interaction
GB9606851D0 (en) Improvements relating to the manufacture of sleeper rings
UA30250A (uk) Антиоксидантний засіб
MX9706424A (es) Uso de la moxonidina para el tratamiento de la aterosclerosis.